CERS:NASDAQ
Cerus Corp
$2.65
arrow_downward
-0.38%(-0.0100) 1D
$2.65
0.00% (0.00)
bedtimeAfter hours
Closed: Sep 18, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CERS...
Open
$2.66
High
$2.68
Low
$2.58
Mkt. cap
534.04M
Avg. vol.
1.83M
Volume
3.57M
52-wk high
$3.47
52-wk low
$1.30
EPS
-$0.03
Beta
1.80
Shares outstanding
201.52M
No. of employees
268
Open
$2.66
High
$2.68
Low
$2.58
Mkt. cap
534.04M
Avg. vol.
1.83M
Volume
3.57M
52-wk high
$3.47
52-wk low
$1.30
EPS
-$0.03
Beta
1.80
Shares outstanding
201.52M
No. of employees
268
News stories
From web sources and news partners
CarePlus VietNam
·
1 week ago
CERS Q2 2026 Earnings: Narrower-Than-Expected Loss of -$0.01 Overshadowed by 1.93% Share Decline - Financial Summary
CarePlus VietNam
·
1 month ago
CERS Q1 2026 Earnings: EPS Surpasses Estimates by 75% as Narrower Loss Reported - ROA Comparison
Profile
Cerus Corporation is an American multinational biotechnology company headquartered in Concord, California that develops and provides a treatment system to pathogen-reduce human blood products for the healthcare industry. Wikipedia
About Cerus Corp
CEO-
Employees268
FoundedSep 1991
HeadquartersConcord, California, United States
SectorMedical device
Websitecerus.com